Agilent Technologies (A) Shares Bought by KCM Investment Advisors LLC

KCM Investment Advisors LLC grew its stake in shares of Agilent Technologies (NYSE:A) by 10.5% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 18,117 shares of the medical research company’s stock after purchasing an additional 1,719 shares during the quarter. KCM Investment Advisors LLC’s holdings in Agilent Technologies were worth $1,212,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently added to or reduced their stakes in the company. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. increased its holdings in shares of Agilent Technologies by 1.6% in the 4th quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 48,835 shares of the medical research company’s stock valued at $3,385,000 after acquiring an additional 771 shares during the period. Signature Estate & Investment Advisors LLC increased its holdings in shares of Agilent Technologies by 7.3% in the 4th quarter. Signature Estate & Investment Advisors LLC now owns 11,406 shares of the medical research company’s stock valued at $764,000 after acquiring an additional 773 shares during the period. Penserra Capital Management LLC increased its holdings in shares of Agilent Technologies by 18.6% in the 4th quarter. Penserra Capital Management LLC now owns 5,320 shares of the medical research company’s stock valued at $356,000 after acquiring an additional 836 shares during the period. Weatherly Asset Management L. P. increased its holdings in shares of Agilent Technologies by 18.3% in the 4th quarter. Weatherly Asset Management L. P. now owns 5,668 shares of the medical research company’s stock valued at $380,000 after acquiring an additional 876 shares during the period. Finally, New Mexico Educational Retirement Board increased its holdings in shares of Agilent Technologies by 3.0% in the 4th quarter. New Mexico Educational Retirement Board now owns 30,893 shares of the medical research company’s stock valued at $2,069,000 after acquiring an additional 900 shares during the period.

A number of equities analysts have recently commented on A shares. Zacks Investment Research cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Wednesday. ValuEngine raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Thursday, March 1st. Morgan Stanley cut their target price on shares of Agilent Technologies from $95.00 to $91.00 and set an “overweight” rating on the stock in a report on Wednesday, April 11th. JPMorgan Chase lifted their target price on shares of Agilent Technologies from $75.00 to $80.00 and gave the company an “overweight” rating in a report on Thursday, February 15th. Finally, Cowen raised shares of Agilent Technologies from a “market perform” rating to an “outperform” rating in a report on Tuesday. Three investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $72.20.

In other Agilent Technologies news, insider Patrick Kaltenbach sold 6,875 shares of the business’s stock in a transaction on Monday, March 12th. The shares were sold at an average price of $71.38, for a total transaction of $490,737.50. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Heidi Fields sold 5,000 shares of the business’s stock in a transaction on Tuesday, March 27th. The stock was sold at an average price of $68.09, for a total transaction of $340,450.00. Following the sale, the director now owns 57,563 shares in the company, valued at $3,919,464.67. The disclosure for this sale can be found here. Insiders sold a total of 22,700 shares of company stock worth $1,586,452 over the last three months.

Shares of Agilent Technologies opened at $64.32 on Friday, according to Marketbeat. The company has a debt-to-equity ratio of 0.39, a quick ratio of 2.78 and a current ratio of 3.32. The firm has a market capitalization of $20.51 billion, a price-to-earnings ratio of 27.25, a PEG ratio of 2.22 and a beta of 1.32. Agilent Technologies has a 1 year low of $55.85 and a 1 year high of $75.00.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Monday, May 14th. The medical research company reported $0.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.64 by $0.01. The company had revenue of $1.21 billion for the quarter, compared to analysts’ expectations of $1.21 billion. Agilent Technologies had a net margin of 5.02% and a return on equity of 18.01%. Agilent Technologies’s revenue was up 9.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.58 EPS. equities research analysts expect that Agilent Technologies will post 2.67 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 25th. Shareholders of record on Tuesday, July 3rd will be paid a $0.149 dividend. The ex-dividend date of this dividend is Monday, July 2nd. This represents a $0.60 annualized dividend and a yield of 0.93%. Agilent Technologies’s dividend payout ratio is currently 25.42%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply